Tanudisastro, Hope A. http://orcid.org/0000-0002-4561-305X
Deveson, Ira W. http://orcid.org/0000-0003-3861-0472
Dashnow, Harriet http://orcid.org/0000-0001-8433-6270
MacArthur, Daniel G. http://orcid.org/0000-0002-5771-2290
Article History
Accepted: 6 December 2023
First Online: 16 February 2024
Competing interests
: D.G.M. is a paid adviser to GlaxoSmithKline, Insitro, Variant Bio and Overtone Therapeutics and has received research support from AbbVie, Astellas, Biogen, BioMarin, Eisai, Merck, Pfizer and Sanofi-Genzyme; none of these activities are related to the work presented here. I.W.D. has previously received travel and accommodation expenses from ONT to speak at conferences. I.W.D. has a paid consultant role with Sequin Pty Ltd. H.A.T and H.D. declare no competing interests.